Kimberly-Clark/Kenvue: Key EU Regulators to Discuss Deal, Sources Say

Kimberly-Clark/Kenvue: Brussels Expected to Approve Tie-Up with Remedies in Phase 1, Sources Say

The European Commission is expected to approve Kimberly-Clark’s (KMB) $48.7 billion proposed acquisition of Kenvue, with remedies, having so far found that the overlap between the companies’...

The European Antitrust Agenda: Commission Ignores Chinese Blocking Orders; Brussels Hosts Digital Rulebook Meeting on Browsers

Welcome to The European Antitrust Agenda, our weekly overview of European tech and competition law developments. Key stories we’re following this week include: • Commission ignores Chinese...

Antitrust Agenda: Trump Faces Rising Midterm Threat from Tariff Battle with Canada; Comments in Tunney Act Review of DOJ’s Live Nation Settlement Focus on Corruption, Insufficient Remedies; Big Whiskey Distiller Commends Rivals for ‘Rational’ Decisions to Keep Prices High, Cut Supply

Welcome to The Antitrust Agenda, our weekly analysis of timing and priorities at the FTC, DOJ, and state AG offices. Key stories we’re following this week include: • Trade war with Canada...